Risankizumab trials for Psoriasis

All Risankizumab trials · All Psoriasis trials

Phase breakdown

Recruiting trials studying Risankizumab for Psoriasis

• A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
  NCT06100744 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · 34 locations
• Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
  NCT06641089 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 143 locations
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
  NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
  NCT06865105 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 37 locations
• Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
  NCT04846959 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 4 locations

Common questions

How many trials study Risankizumab for Psoriasis?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.